Arkolith/Insider Trading/INBP/Form 4

DeSantis Damon

Director, 10% OwnerINTEGRATED BIOPHARMA INC (INBP) · full profile →Form 4 · filed Apr 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2026Gift(G)9.0M—$010.5M
Apr 15, 2026Gift(G)2.2M—$012.7M

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001345281-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML